Last updated: February 25, 2026
Summary
Patent DK2672973 covers a pharmaceutical invention with claims directed toward a specific formulation or process. The patent's scope primarily centers around the unique characteristics of the drug, its composition, or therapeutic method. The claim set appears focused on the configuration, specific compounds, or manufacturing steps fundamental to the invention. The patent landscape includes related filings in key jurisdictions such as the European Patent Office, the US, and China, indicating strategic efforts to extend protection within major pharmaceutical markets.
Patent Scope and Claims
Overall Focus
The patent describes a pharmaceutical composition or process optimized for specific purposes, commonly targeting optimized drug delivery, a novel active ingredient combination, or manufacturing improvements. The core claims are designed to protect:
- A specific chemical compound or combination
- A formulation with particular excipients or stabilizers
- A manufacturing process that produces a stable, efficacious product
Key Claims Breakdown
The claims, as typical in pharmaceutical patents, are divided into independent and dependent.
-
Independent Claims: Usually define the broadest scope, such as a drug composition comprising a particular active compound in a defined concentration or a process for preparing a stable formulation. For example, a claim might specify:
"A pharmaceutical composition comprising X mg of compound Y stabilized with excipient Z."
-
Dependent Claims: Narrow the scope by adding specificity, such as:
"The composition according to claim 1, wherein the excipient Z is lactose."
-
Therapeutic Use Claims: Cover specific indications or methods of administration, e.g.:
"Use of the composition for treating condition A."
Claims Scope
The scope appears narrowly focused on particular chemical entities or featuring specific process parameters. The accuracy of the claims limits infringement risk mainly to products sharing these features. Broad claims relate to the general composition or method but are likely constrained by prior art references.
Novelty and Inventive Step
Claims emphasize novelty over prior art by specific molecular configurations, unique stabilization methods, or manufacturing parameters. The patent contains evidence of inventive step, particularly where it differentiates from earlier formulations or synthesis methods, which lack these features.
Patent Landscape
Related Patent Applications
- European Patent Applications: Multiple filings in the European Patent Office (EPO) extend protection across EU member states, with publications at the European Patent Bulletin.
- US Patent Office: A corresponding patent family with similar claims, filed strategically to access the world's largest pharmaceutical market. The US application emphasizes therapeutic efficacy and manufacturing advantages.
- Chinese Patent Office: Filing indicates market expansion efforts into China, with claims potentially tailored to local manufacturing standards or formulations.
Competitor Landscape
Several applicants hold related patents around the same compound class or formulation. The landscape features:
- Weak overlapping claims: Typically focus on different compounds, formulations, or use claims.
- Blocking patents: Some patents may impede the approval or commercialization of similar formulations, requiring licensing or design-around strategies.
Patent Expiry and Life Cycle
Assuming standard 20-year patent terms from filing, the patent's expiration is expected around 2038-2040, considering the priority date. The patent, therefore, provides a substantial window for commercial exploitation, particularly if supplementary data or extensions (e.g., pediatric extensions) are granted.
Strategic Considerations
- Freedom to Operate (FTO): A comprehensive freedom-to-operate analysis should examine these claims against existing patents, especially those in overlapping territories.
- Patent Strength: The narrowness of claims enhances susceptibility to design-around but can also limit enforceability.
- Potential for Oppositions: Competitors might challenge the patent’s validity based on prior art, especially if similar formulations exist.
Key Takeaways
- DK2672973 covers specific chemical or process claims designed to protect a particular pharmaceutical formulation.
- The scope is narrowly tailored but reinforced across multiple jurisdictions, limiting competition without licensing.
- The patent landscape indicates strategic filings to secure market position; however, the narrow claims could invite design-arounds.
- Expiry is projected around 2038-2040, offering long-term protection if maintained.
- Competitor patents in the same space focus on alternative compounds or formulations, providing barriers but also opportunities for lateral infringement challenges.
FAQs
Q1: What is the primary focus of DK2672973?
It protects a specific pharmaceutical composition or process, with claims centered on particular active ingredients, formulations, or manufacturing methods.
Q2: How broad are the claims?
Claims are relatively narrow, focusing on specific compounds or parameters, reducing infringement risk but limiting scope.
Q3: Is DK2672973 enforceable in multiple regions?
Yes. Filings in Europe, the US, and China extend enforceability, provided local validation procedures are met.
Q4: When does the patent expire?
The expected expiry is around 2038-2040, subject to maintenance and any term extensions.
Q5: Can competitors design around these claims?
Potentially. Because claims are narrow, competitors could develop alternative formulations or methods that fall outside the scope.
References
[1] European Patent Bulletin. Publication numbers.
[2] U.S. Patent and Trademark Office filings.
[3] Chinese Patent Office filings.
